Home > Journals > Minerva Anestesiologica > Past Issues > Minerva Anestesiologica 2012 October;78(10) > Minerva Anestesiologica 2012 October;78(10):1146-53

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA ANESTESIOLOGICA

A Journal on Anesthesiology, Resuscitation, Analgesia and Intensive Care


Official Journal of the Italian Society of Anesthesiology, Analgesia, Resuscitation and Intensive Care
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 2,036


eTOC

 

EXPERT OPINIONS  


Minerva Anestesiologica 2012 October;78(10):1146-53

language: English

Recent advances in interfaces for non-invasive ventilation: from bench studies to practical issues

Sferrazza Papa G. F. 1, 2, Di Marco F. 2, Akoumianaki E. 1, 3, Brochard L. 1, 4

1 Intensive Care Department, University Hospital, Geneva, Switzerland;
2 Clinica di Malattie dell’Apparato Respiratorio, Ospedale San Paolo, Università degli Studi di Milano, Milano, Italia;
3 Department of Intensive Care Medicine, University Hospital of Heraklion, Heraklion, Crete, Greece;
4 University of Geneva, Geneva, Switzerland


FULL TEXT  


The interface is the defining element of non-invasive ventilation (NIV). Nowadays different types of interfaces, which differ in terms of shape, mechanical properties and comfort, are available, and their choice and fitting is a key element of NIV success. In the last decade, larger masks covering the entire face and specifically designed helmets have been developed for delivering NIV, theoretically improving comfort and patient tolerance. Recent studies have shown that, despite marked heterogeneity in mask internal volume and compliance, the dynamic dead space and, above all, the clinical efficacy of different masks is on average very similar. Thus, with the exception of the nasal mask and the mouthpiece, a variety of interfaces for NIV can be used in the acute care setting. However, prevention and monitoring of interfaces related side-effects and evaluation of patient tolerance are crucial to avoid NIV failure. To optimize effectiveness and costs, an interface strategy for NIV in acute respiratory failure could be convenient in clinical practice.

top of page

Publication History

Cite this article as

Corresponding author e-mail

laurent.brochard@hcuge.ch